RBFOX2 and hepatocellular carcinoma: Chen et al, found that the low expression of hsa-miR-200a in hepatocellular carcinoma cells, and it could inhibit the proliferation, migration and invasion of hepatocellular carcinoma cells by targeting FOX2, suggesting that miR-200a might be used as a therapeutic molecule for liver cancer[33].